TY - JOUR
T1 - Second trimester ultrasound prenasal thickness combined with nasal bone length
T2 - A new method of Down syndrome screening
AU - Maymon, Ron
AU - Levinsohn-Tavor, Orna
AU - Cuckle, Howard
AU - Tovbin, Yosef
AU - Dreazen, Eli
AU - Wiener, Yifat
AU - Herman, Arie
PY - 2005/10
Y1 - 2005/10
N2 - Objective: To evaluate ultrasound prenasal thickness (PT) as a way of enhancing the Down syndrome (DS) screening performance of second-trimester nasal bone (NB) length measurement. Methods: Twenty-one DS and 500 normal fetuses were scanned at 14-27 weeks' gestation. The affected karyotype was known to the person performing the scan. Both PT and NB were measured in a mid-sagittal position and results were expressed in multiples of the normal gestation-specific median (MoM). Gaussian modelling was used to predict the performance of routine screening. Results: Among DS fetuses, the PT median was 1.35 MoM, a highly statistically significant increase compared with the unaffected pregnancies (p < 0.0001, Wilcoxon Rank Sum Test, two-tailed). The NB median was 0.87 MoM (p < 0.0005) and the ratio PT/NB median was 1.51 MoM (p < 0.0001). In the normal fetuses, the two markers were positively correlated (0.25, p < 0.0001), whereas in the DS fetuses there was a non-significant negative correlation (-0.24, p = 0.33). For a 5% false-positive rate, the model predicted detection rate was 70% for PT and NB compared with 43% for NB alone. Conclusion: In the second trimester, PT is increased on average in DS fetuses. Combining PT and NB measurement could yield a higher screening detection rate than NB alone. Confirmation of our findings in a series of women scanned before the karyotype was known is needed before the method can be clinically implemented.
AB - Objective: To evaluate ultrasound prenasal thickness (PT) as a way of enhancing the Down syndrome (DS) screening performance of second-trimester nasal bone (NB) length measurement. Methods: Twenty-one DS and 500 normal fetuses were scanned at 14-27 weeks' gestation. The affected karyotype was known to the person performing the scan. Both PT and NB were measured in a mid-sagittal position and results were expressed in multiples of the normal gestation-specific median (MoM). Gaussian modelling was used to predict the performance of routine screening. Results: Among DS fetuses, the PT median was 1.35 MoM, a highly statistically significant increase compared with the unaffected pregnancies (p < 0.0001, Wilcoxon Rank Sum Test, two-tailed). The NB median was 0.87 MoM (p < 0.0005) and the ratio PT/NB median was 1.51 MoM (p < 0.0001). In the normal fetuses, the two markers were positively correlated (0.25, p < 0.0001), whereas in the DS fetuses there was a non-significant negative correlation (-0.24, p = 0.33). For a 5% false-positive rate, the model predicted detection rate was 70% for PT and NB compared with 43% for NB alone. Conclusion: In the second trimester, PT is increased on average in DS fetuses. Combining PT and NB measurement could yield a higher screening detection rate than NB alone. Confirmation of our findings in a series of women scanned before the karyotype was known is needed before the method can be clinically implemented.
KW - Down syndrome
KW - Nasal bone
KW - Prenasal thickness
KW - Screening
KW - Ultrasound
UR - http://www.scopus.com/inward/record.url?scp=27144436854&partnerID=8YFLogxK
U2 - 10.1002/pd.1207
DO - 10.1002/pd.1207
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:27144436854
SN - 0197-3851
VL - 25
SP - 906
EP - 911
JO - Prenatal Diagnosis
JF - Prenatal Diagnosis
IS - 10
ER -